C.M. Bidwell & Associates’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-894
| Closed | -$118K | – | 528 |
|
|
2023
Q4 | $118K | Buy |
894
+5
| +0.6% | +$659 | 0.09% | 147 |
|
|
2023
Q3 | $100K | Buy |
+889
| New | +$100K | 0.08% | 230 |
|
|
2023
Q1 | – | Sell |
-419
| Closed | -$50K | – | 544 |
|
|
2022
Q4 | $50K | Hold |
419
| – | – | 0.04% | 288 |
|
|
2022
Q3 | $45K | Buy |
+419
| New | +$45K | 0.04% | 279 |
|
|
2018
Q4 | – | Sell |
-275
| Closed | -$34K | – | 441 |
|
|
2018
Q3 | $34K | Buy |
+275
| New | +$34K | 0.03% | 257 |
|